Julia Ernst, MS

Neuro-oncologists must grapple daily with precarious brain tumors that are often masked by common symptoms such as a headache or seizure.

The modified pediatric Alberta Stroke Program Early CT Score correlated with stroke severity, hemorrhagic transformation and 1-year outcomes among children with supratentorial ischemic stroke, according to findings published in Neurology.

Increased levels of neurofilament light in plasma samples correlated with a greater risk for ALS, according to findings from an analysis of plasma samples obtained within 5 years of an ALS diagnosis that was published in Neurology.

Oral atogepant once per day effectively decreased the number of migraine and headache days over 12 weeks, according to findings from the phase 3 ADVANCE trial that were published in The New England Journal of Medicine.

The correlation between age and contrast-enhancing lesions “is a general phenomenon” across the MS spectrum of disease, according to an analysis of four large, randomized controlled trials published in Neurology.

A transport policy for emergency medical services resulted in a substantial and swift increase in rates of endovascular therapy after acute ischemic stroke, according to findings from a single-center study published in JAMA Neurology.

Findings published recently in Journal of Medical Economics demonstrated that patients with focal seizures who began first adjunctive therapy with eslicarbazepine acetate vs. brivaracetam had considerably larger reductions in medical costs.

Physical activity correlated with decreased all-cause mortality in a dose-dependent matter among individuals with a history of stroke, especially younger individuals, according to findings published in Neurology.

Children with a neurologic comorbidity experienced an almost twofold greater risk for postoperative pneumonia, according to results from a retrospective study published in Pediatrics.

The American Academy of Neurology has issued what it described as a formal position that, barring an “absolute contraindication” to available vaccine formulations, eligible patients should be offered the COVID-19 vaccine.